INS and metabolic dysfunction-associated steatotic liver disease: The positive association between serum insulin levels and the prevalence of NAFLD remained consistent across various sensitivity analyses, including exclusion of participants with missing data, those receiving insulin therapy, those taking insulin secretagogues, all diabetic participants, and those with extreme serum insulin values.